In a series of animal experiments and a clinical study, Mojsov and her collaborators subsequently demonstrated that the GLP-1 peptide increases insulin production when administered by injection, causing blood glucose levels to drop
It is administered as a once-weekly injection, with dose gradually escalated to the 2.4 mg target dose if tolerated
References Seidenberg AB, Julian AK, Hartman AM, Holman DM
2013;100(3):S35
At the same time, prioritizing these medications can shift the focus from sustainable efforts like learning to make satiating food choices, managing stress, and expanding access to healthier options
In private practice, she advised clients on immigration and contractual matters and prepared cases for trial